Last reviewed · How we verify

Ibuprofen/acetaminophen

Montefiore Medical Center · FDA-approved active Small molecule

Ibuprofen/acetaminophen is a Analgesic/antipyretic combination (NSAID + non-NSAID analgesic) Small molecule drug developed by Montefiore Medical Center. It is currently FDA-approved for Mild to moderate pain, Fever reduction, Headache. Also known as: Ibuprofen/paracetamol (lower dose).

Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, while acetaminophen inhibits prostaglandin synthesis and modulates pain perception centrally.

Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, while acetaminophen inhibits prostaglandin synthesis and modulates pain perception centrally. Used for Mild to moderate pain, Fever reduction, Headache.

At a glance

Generic nameIbuprofen/acetaminophen
Also known asIbuprofen/paracetamol (lower dose)
SponsorMontefiore Medical Center
Drug classAnalgesic/antipyretic combination (NSAID + non-NSAID analgesic)
TargetCyclooxygenase (COX-1, COX-2) for ibuprofen; prostaglandin synthesis and central pain pathways for acetaminophen
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that blocks COX-1 and COX-2 enzymes, reducing production of inflammatory prostaglandins and providing analgesic, antipyretic, and anti-inflammatory effects. Acetaminophen (paracetamol) works primarily through central inhibition of prostaglandin synthesis and modulation of pain and temperature regulation pathways. The combination provides complementary analgesic and antipyretic effects with potentially improved efficacy over either agent alone.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ibuprofen/acetaminophen

What is Ibuprofen/acetaminophen?

Ibuprofen/acetaminophen is a Analgesic/antipyretic combination (NSAID + non-NSAID analgesic) drug developed by Montefiore Medical Center, indicated for Mild to moderate pain, Fever reduction, Headache.

How does Ibuprofen/acetaminophen work?

Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, while acetaminophen inhibits prostaglandin synthesis and modulates pain perception centrally.

What is Ibuprofen/acetaminophen used for?

Ibuprofen/acetaminophen is indicated for Mild to moderate pain, Fever reduction, Headache, Musculoskeletal pain.

Who makes Ibuprofen/acetaminophen?

Ibuprofen/acetaminophen is developed and marketed by Montefiore Medical Center (see full Montefiore Medical Center pipeline at /company/montefiore-medical-center).

Is Ibuprofen/acetaminophen also known as anything else?

Ibuprofen/acetaminophen is also known as Ibuprofen/paracetamol (lower dose).

What drug class is Ibuprofen/acetaminophen in?

Ibuprofen/acetaminophen belongs to the Analgesic/antipyretic combination (NSAID + non-NSAID analgesic) class. See all Analgesic/antipyretic combination (NSAID + non-NSAID analgesic) drugs at /class/analgesic-antipyretic-combination-nsaid-non-nsaid-analgesic.

What development phase is Ibuprofen/acetaminophen in?

Ibuprofen/acetaminophen is FDA-approved (marketed).

What are the side effects of Ibuprofen/acetaminophen?

Common side effects of Ibuprofen/acetaminophen include Gastrointestinal upset, Nausea, Dyspepsia, Hepatotoxicity (acetaminophen component at high doses), Renal impairment (ibuprofen component).

What does Ibuprofen/acetaminophen target?

Ibuprofen/acetaminophen targets Cyclooxygenase (COX-1, COX-2) for ibuprofen; prostaglandin synthesis and central pain pathways for acetaminophen and is a Analgesic/antipyretic combination (NSAID + non-NSAID analgesic).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing